Literature DB >> 12379256

Effect of orphanin FQ on interleukin-1beta mRNA transcripts in the rat CNS.

H Zhao1, H-W Huang, G-C Wu, X-D Cao.   

Abstract

To elucidate the mechanism of orphanin FQ on neuroimmune modulation, the relationship between orphanin FQ and interleukin-1beta in the rat CNS in vivo and in vitro was investigated. In our experiments, it was found that orphanin FQ and interleukin-1beta mRNA transcripts showed a similar distribution in cerebral cortex, hippocampus and hypothalamus. By using the in situ hybridization technique, down-regulation of interleukin-1beta mRNA transcripts by central administration of orphanin FQ was further identified in the traumatic animal model. Similar inhibitory effects were also observed on the number of microglia in the CNS. The effects produced by orphanin FQ were abolished by combination with its receptor (OP(4))-specific antagonist [Phe(1)Psi(CH(2)-NH)Gly(2)]nociceptin-(1-13)-NH(2), which suggested that the function of orphanin FQ might be attributable to the OP(4) pathway. However, the effect on the number of astrocytes in the CNS remained unchanged, despite evidence that OP(4) is expressed on astrocytes as well as on neurons and microglia. When analyzed by reverse transcription-polymerase chain reaction, interleukin-1beta gene expression was observed to be enhanced and inhibited in primary neuron and microglial cell cultures exposed to orphanin FQ respectively. Interleukin-1beta gene expression in astrocyte cultures was not affected by treatment with orphanin FQ. Our findings suggest that the neuroimmune function of orphanin FQ might be dependent on interleukin-1beta derived from microglia, and the interaction between microglia and neurons.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379256     DOI: 10.1016/s0306-4522(02)00233-6

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  9 in total

1.  Beta-funaltrexamine inhibits inducible nitric-oxide synthase expression in human astroglial cells.

Authors:  Randall L Davis; Daniel J Buck; Neda Saffarian; Shekher Mohan; Udaya DeSilva; Samodha C Fernando; Craig W Stevens
Journal:  J Neuroimmune Pharmacol       Date:  2008-02-16       Impact factor: 4.147

2.  Neurite outgrowth is dependent on the association of c-Src and lipid rafts.

Authors:  Hui Zhao; Xiaoding Cao; Gencheng Wu; Horace H Loh; Ping-Yee Law
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

3.  Age-Dependent Neuroimmune Modulation of IGF-1R in the Traumatic Mice.

Authors:  Hui Zhao; Xiaocong Zhao; Xiaoding Cao; Gencheng Wu
Journal:  Immun Ageing       Date:  2012-05-28       Impact factor: 6.400

4.  NOP Receptor Ligands as Potential Agents for Inflammatory and Autoimmune Diseases.

Authors:  Elaine C Gavioli; Pedro R T Romão
Journal:  J Amino Acids       Date:  2011-11-17

5.  Neuroimmune modulation following traumatic stress in rats: evidence for an immunoregulatory cascade mediated by c-Src, miRNA222 and PAK1.

Authors:  Hui Zhao; Ranran Yao; Xiaoding Cao; Gencheng Wu
Journal:  J Neuroinflammation       Date:  2011-11-14       Impact factor: 8.322

Review 6.  The role of orphanin FQ/nociceptin in neuroplasticity: relationship to stress, anxiety and neuroinflammation.

Authors:  Elyse M Mallimo; Alexander W Kusnecov
Journal:  Front Cell Neurosci       Date:  2013-10-08       Impact factor: 5.505

7.  Endogenous nociceptin / orphanin FQ system involvement in hypothalamic-pituitary-adrenal axis responses: relevance to models of inflammation.

Authors:  J D Leggett; K L Dawe; D S Jessop; A J Fulford
Journal:  J Neuroendocrinol       Date:  2009-09-01       Impact factor: 3.627

8.  Inflammatory mediators influence the expression of nociceptin and its receptor in human whole blood cultures.

Authors:  Lan Zhang; Frank Stuber; Ulrike M Stamer
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

Review 9.  Opioid Receptors in Immune and Glial Cells-Implications for Pain Control.

Authors:  Halina Machelska; Melih Ö Celik
Journal:  Front Immunol       Date:  2020-03-04       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.